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Abstract 
In the past several months, the globe was overwhelmed by the 
novel coronavirus (COVID-19) pandemic. As rising number of 
documented cases and mortality toll continued to be reported, it 
is imperative to reexamine the current healthcare system as well 
as consider the repercussion on medical society. The condition 
in Taiwan, although expected critical regarding close intertwine 
with epicenter, was relatively stable thus far given multiple ef-
forts paid, suggesting the experiences here may serve as a refer-
ence for other countries. The aim of this article was to illustrate 
the aggravation of COVID-19 status and how Taiwan corre-
sponded to the crisis. First, national team production and name-
based allocation, followed by map-directed and online pre-order 
system, ensured the public to obtain enough surgical masks. Sec-
ond, constant advocacy of the quarantine policies and personal 
hygiene, in conjunction with regular press conference by offi-
cials, accomplished message transparency and citizens’ literacy 
upon the situation. Third, establishment of the traffic control 
bundle successfully antagonized nosocomial infection and pre-
vented subsequent clusters. Forth, biomedical research not only 
propelled the elucidation of the COVID-19 pathogenesis but also 
facilitated the development of potential medications. Further-
more, the impact on medical education was delineated. Reorgan-
ization of training curriculum, distance learning, and the practice 
of virtual meeting reshaped the landscape of clinical training. In 
conclusion, through conscientious appraisal on how we con-
fronted COVID-19 will the community be better prepared for the 
next pandemic. 
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In December 2019, a cluster of 
cases sustaining pneumonia of unknown 
causes occurred in Wuhan, Hubei province, 
Mainland China1. These patients were char-
acterized by their shared exposure to veni-
son and raw seafood. Although local gov-
ernment fleetly lockdown the Huanan 
wholesale market and further sanitized such 
area, the outbreak of a novel coronavirus 
became inevitable2. After sequencing the 
viral genome, the culprit pathogen was 
demonstrated to harbor similar yet not iden-
tical genetic landscape with either severe 
acute respiratory syndrome coronavirus 
(SARS-CoV) or Middle East Respiratory 
Syndrome (MERS-CoV)3. Domestic pa-
tient count skyrocketing, China filed the 
first mortality report, a 61-year-old gentle-
man, on January 11th, 2020, followed by the 
summary of clinical vignettes among those 
firstly affected as well as epidemiological 
statistics4. Thailand also diagnosed the 
premier case of the novel coronavirus on 
January 13th, 2020. World Health Organiza-
tion (WHO) eventually declared “Public 
Health Emergency of Global Concern” on 
January 30th, 2020, and later officially 
named the disease COVID-195. On March 
12th, 2020, COVID-19 was recognized as 
pandemic6, and human-to-human transmis-
sion was affirmed7. 
Over the next two months, due to 
airline travel, cruise trip, and cargo trans-
portation, the total diagnosed cases of 
COVID-19 reached a quarter million, with 
more than 13,000 affected individuals un-
fortunately expired at the end of March 
2020. Despite the fact that vast majority of 
the deceased were the elderly, obese, with 
smoking history, immunocompromised, or 
with significant cardiopulmonary underly-
ing illness8, a great quantity of middle-aged 
citizens who contributed to the central 
working power were designated as proba-
ble or certain cases and thereby obligated 
for 14-day isolation. Conjunctionally, city 
was blocked, migration ceased, boutique 
closed, and society distanced. The pan-
demic gradually teared the global village 
apart. The aim of this article is both to re-
visit the policies administered in Taiwan 
and further to illustrate the impact on med-
ical students both upon curriculum arrange-
ment and clinical participation.
 
Condition in Taiwan 
On Taiwanese perspective, consid-
ering the geographic proximity to the initial 
epicenter of COVID-19 as well as previous 
experience of managing SARS-CoV9, vigi-
lance arose in both public and private sec-
tors at the very beginning, followed by ag-
gressive actions to curb the COVID-19 
spreading in a timely manner (Table 1). Po-
litical factor aside, our government imple-
mented rigorous measures to restrict the 
pouring of citizens from across the strait, at-
tempting to withhold the infection. Till 
now, the performance of Taiwan Central 
Epidemic Commend Center (CECC) was 
above average and well-recognized by in-
ternational society. The climb of cumula-
tive cases has yet beyond control (Fig. 1) 
and the total number was among the fewest 
in Asian Medical Student Association 
chapters (Fig. 2). Minimal community 
spread and least nosocomial contagion 
bought our medical facilities and logistic 
industries more time to expand hospital ca-
pacity and avoid society breakdown. The 
aim of this review is to summarize the pol-
icies by Taiwanese government for appre-
hension of COVID-19 and illustrate the im-
pact upon medical students (Fig. 3). 
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Figure 1. Timeline of policies implemented by Taiwan government (until March, 2020). 
 
Figure 2. Statistics of confirmed cases and mortality tolls among 17 Asian Medical Student 
Association (AMSA) chapters (until 12th week of 2020). 
 
Figure 3. Graphic summary of COVID-19 management in Taiwan. 
 
Allocation of surgical mask 
Maintaining adequate number of 
surgical masks both augmented the block-
ade of infection and carried implication to 
stabilize public sentiment. Because of in-
fectious meningitis in Tainan around 1920s 
and SARS nationwide in 2003, Taiwanese 
culture is traditionally compatible with the 
donning of masks even in usual times. Be-
fore the COVID-19 outbreak, daily produc-
tion of mask in Taiwan was 1.88 million 
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pieces on average. To guarantee adequate 
domiciliary reserves, President of Execu-
tive Yuan forbade the export of surgical 
mask, albeit controversies over ethical con-
sideration from opposition parties, on Janu-
ary 24th, 2020. Additionally, multiple giant 
enterprises, including Foxconn, Hiwin 
Technologies, and Taiwan Takisawa Com-
pany, etc, volunteered to join the “national 
team”, expediting the industrial manufac-
ture. Influx of soldiers’ assistance, lucrative 
funding up to 180 million new Taiwanese 
dollars (NTD) (5.95 million US dollars) for 
expropriated factory, and 24/7 shift acceler-
ated the assembly line. Until middle March, 
13 million adult masks plus 5.5 million pe-
diatric masks were provided per day.  
To track the circulation of goods, on 
January 31st, 2020, CECC issued for unified 
allocation of surgical masks by central gov-
ernment10. Setting the price at 7 NTD per 
piece and restricted to purchase at most 
three pieces per day per person, a panic-
buying spree, nonetheless, ensued. In re-
sponse, 6 days later the mask rationing plan 
was executed. Citizens were requested to 
present their National Health Insurance 
card at contracted pharmacies or any 220 
township public health centers around the 
island before one could acclaim the weekly 
ration thereof. However, due to the differ-
ences in population density and urban-rural 
gap, a considerable amount of time was 
spent on queueing for limited products in 
certain area, whereas other stores still 
housed abundant masks at stock. Corre-
spondingly, Minister of State without Port-
folio designed Taiwan Mask Map to direct 
people toward appropriate emporium in 
real-time via global positioning system. 
Furthermore, on March 12th, 2020, refined 
mask distribution system commenced. In-
corporating internet network and logistic 
business, residents could pre-order surgical 
masks via eMASK application online and 
received the merchandise about one week 
later at local convenience stores (ibon, 
FamiPort, Life-ET, OK Go). These policies 
together accomplished both steady and fair 
supply of surgical masks in the society.
 
Message update and transparency 
Risk and outbreak communication 
was gradually instituted in the post-SARS 
era11. Since the first several patients of 
COVID-19 were reported in the island, 
CECC has been holding press conference 
regularly, if not daily, to update the citizens 
on the statistics of new documented cases 
and advocating the prophylactic measures 
on disease control in additional to strength-
ening personal hygiene. Medias were free 
to raise any relevant questions, which 
would be answered by the professional 
panel directly and simultaneously be broad-
casted nationwide. In addition, the author-
ity filmed a sequence of brief television ad-
vertisements with doctors at local clinic, ce-
lebrities, Dean of medical college, and the 
vice president Professor Chien-Jen Chen. 
The purpose of these clips was to under-
score different aspects of the preventive 
program, including the correct procedure of 
hand washing, proper timing to wear surgi-
cal mask, appropriate way to cleanse the en-
vironment, and urging the public to replace 
hatred with support toward the quarantined 
individuals.  
    Besides, to endorse the accurate 
streaming of information and to subdue fic-
titious message, the executive officials on 
February 25th, 2020, promptly passed 《
Prevention and Bailout for Infectious Pneu-
monia Special Act》. Those who either 
fabricated or disseminated any rumors on 
purpose would be fined at the maximum of 
3 million NTD or be sentenced up to 3 years 
in prison. Meanwhile, National Communi-
cations Commission ordered the social net-
work website to delete false comments on 
COVID-19 and block the culprit IP address, 
if necessary, so as to aware users of the au-
thentic situation. Securing the openness and 
transparency of the COVID-19 updates
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Table 1. Timeline of policies implemented by Taiwan government (until March, 2020). 
Date (2020) Policy Purpose 
January 20th Found CECC* For unified commend 
January 24th Prohibit mask export To ensure sufficient supply 
January 31st Unified mask allocation For fair distribution 
February 6th Mask rationing plan To achieve general allocation 
February 6th Postpone hospital accreditation To advocate for concentration on 
disease control 
February 20th Homemade Remdesivir ready To facilitate pharmaceutical de-
velopment 
February 23rd Ban medical personnel from trav-
eling abroad† 
To affirm adequate manpower 
February 25th Special Act legislation To punish fictitious news and 
budget industry bailout 
February 29th Demand medical students to tem-
porarily leave X hospital‡ 
To avoid further nosocomial in-
fection 
March 12th Name-based mask distribution 
system 2.0 
Online mask pre-order 
March 17th Prohibit teachers & students from 
traveling abroad† 
For prevention of in-campus 
transmission 
March 20th Raise global travel advisory to 
Level III§, 
To discourage cross-border mi-
gration 
*CECC: Central Epidemic Command Center. †Unless otherwise approved. ‡X was used due to anonymity. §Must 
avoid all unnecessary travels. 
paved the way for the establishment of citi-
zen-governor trust as well as the diminish-
ment of widespread restlessness. 
 
Traffic control bundle 
From the beginning of the COVID-
19 epidemic, CECC conjointly with Minis-
try of Foreign Affairs and Mainland Affair 
Council together determined travel advi-
sory alert of other countries based on their 
respective condition. According to Taiwan 
legislation, Level I exercises normal pre-
cautions and no specific requirement for in-
coming travelers is necessitated. Level II 
calls for reinforced safeguarding and all ar-
riving travels from these countries were 
subject to self-health management for 2 
weeks. Level III exhorts the nationals to 
cancel all nonessential travels. Otherwise, 
14 days of home quarantine must be ob-
served upon returning. Until March 20th, 
2020, CECC had raised travel alert to Level 
III on all countries universally in order to 
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consolidate plausible supervision. Plus, for-
eigners have been restricted from entering 
the island. Each airport in Taiwan was 
equipped with infrared laser thermometer 
to routinely and rigorously assess body 
temperature of all incoming traveler at bor-
der for years12, which also helped identify-
ing potential spreader of COVID-19 at the 
earliest possible timing. Upon entrance, the 
contact phone number, however time-con-
suming, would be rechecked by officials. 
On the other hand, toll-free hotline “1922” 
for disease reporting and consultation com-
menced operation since 2003. Most calls 
inquired for influenza vaccine, measles, tu-
berculosis, and acquired immunodeficiency 
disease before the COVID-19. Now “1922” 
was primarily responsible for the coordina-
tion of medical assistance toward those af-
fected travelers. Comprehensive actions on 
the prevention of communicating disease 
have been carried out at the border.  
Besides, meticulous circulation 
planning was performed in hospitals. Since 
SARS-CoV epidemic in Taiwan, Yen et al 
introduced traffic control bundle (TCB), 
aiming to distinguish clean from contami-
nated individuals and items13 (to reviewer: 
Duplication of the message from the cited 
reference might be redundant here). In ad-
dition to personal protective equipment 
(PPE), negative pressure isolation room, 
and barrier nursing station14, TCB was 
proven to be a prerequisite element for 
overcoming this unprecedented crisis. At 
designated fever station outside emergency 
department entrance, febrile subjects were 
specially triaged and completely separated 
from other patients as well as healthcare 
workers. Transition area was created at the 
waiting zone among individuals with dif-
ferent risk of infection15. Increased number 
of hand-washing facilities (i.e. faucets or 
checkpoint alcohol dispensers) was also set 
up, and zone of risk between contaminated 
or clean were unequivocally defined. By 
TCB, likelihood of nosocomial infection 
rate significantly declined during SARS, 
MERS, and Ebola outbreak16,17. Incidence 
of ventilator associated pneumonia and 
central line infection in intensive care unit 
was also significantly reduced18,19. Re-
cently, enhanced TCB approach was intro-
duced. With expended buffer zone, quaran-
tine ward for the accommodation of pa-
tients with atypical symptoms, and fortified 
PPE, Taiwan effectively impede the trans-
mission cycle to date20. Hospital capacity 
(over 1000 negative pressure isolation 
room, currently 70% full) was still ample 
for contemporary condition. These experi-
ences were instructive for our country to 
manage COVID-19 and provided a feasible 
protocol for rest of the world to consider. 
 
Biomedical and pharmaceutical 
preparedness 
Taiwan is renowned for its aptitude 
in biomedical research and pharmaceutical 
development. Technique of reverse tran-
scription polymerase chain reaction to in-
spect the presence of COVID-19 was read-
ily available in the island, and simple kit for 
rapid diagnostic test was collectively estab-
lished by Academic Sinica (AS), with 
United States, European Union, and Czech 
Academy of Sciences. The goal to shorten 
the testing time down to 15 minutes was at-
tempted. Although the apparatus was in 
place, the scope of individuals to be as-
sessed varied from nation to nation. South 
Korea decided to undergo mass testing, alt-
hough some argued that pronounced false 
negative rate might bring about mendacious 
sense of security in the public and thereby 
hampered further infection control. Con-
versely, Taiwan currently chose to permit 
testing only for those with upper respiratory 
symptoms or fever and had travel/exposure 
history, cluster event, otherwise untreatable 
pneumonia, or special occupation. e.g. 
medical staffs or workers in nursing facil-
ity, in accordance to the WHO interim guid-
ance of COVID-19 surveillance21.  
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Pro tem, significant efforts have 
been devoted to appreciate the behavior of 
the novel coronavirus as well as to spot po-
tential therapeutic target. The pathophysiol-
ogy and transmission dynamics were re-
viewed elsewhere22,23,24,25. A wide range of 
medications was repurposed for treating 
COVID-1926. Specifically, the efficacy of 
favipiravir (T-705), Nitazoxanide, Nafa-
mostat, and panciclovir were equivocal, 
whereas Remdesivir (GS-5734) and chloro-
quine were among the first to be proven ef-
fective against the novel coronavirus27. 
Proudly, in two weeks AS synthesized 
homemade Remdesivir 100 mg with purity 
reaching 97% after crystallization. Further 
anecdotal reports and expert consensus 
shed light on the combined therapeutics 
with Hydroxycholoquine (600 mg QD) and 
Azithromycin (loading 500 mg QD on day 
1, then maintained with 250 mg QD)28. Fu-
ture research would be needed to accurately 
discover a drug specific to COVID-19. 
 
Influences on medical students 
The COVID-19 pandemic is closely 
intertwined with medical students. On Feb-
ruary 23rd, 2020, in spite of bitter dispute 
upon legitimacy, CECC firmly banned all 
medical practitioners (including doctors, 
nurses, pharmacists, physical therapists, oc-
cupational therapists, laboratory techni-
cians, nutritionists, etc) from travelling 
abroad unless otherwise approved29 so as to 
warrant sufficient medical labor. Hospital 
accreditation was also adjourned for 1 year. 
Additionally, as escalating number of cases 
confirmed, with some of which among per-
sonnel inside campus, New Taipei City 
government, followed by CECC, an-
nounced travel constraint upon whole 
teachers and students in high school and un-
der on March 17th, 202029,30. Elimination of 
global interactions was believed to be indis-
pensable for combating the outbreak. 
On the other side, fifth (clerkship) 
and sixth grade (sub-internship) of medical 
students in Taiwan are required to observe 
in the hospital. Since the first case of pa-
tient-nurse transmission of COVID-19 in X 
hospital on February 29th, 2020, the author-
ity asked all medical trainees to return to 
their respective universities29. Clinical ap-
prentice was substituted with distance 
learning and virtual presentation. Other 
hospitals and medical universities were also 
concerned about nosocomial spreading, 
thereby disagreed any gathering with more 
than 100 people in enclosed environment or 
250 people outside. Some gathered clerks 
and reallocated them to specific ward for 
minimizing contagious sources and better 
trace for the origin of nosocomial infection 
if present. Plus, morning meeting took 
place as video conferences, grand round put 
off, and seminars postponed. Eventually, 
Asian Medical Student Conference 2020 
was also cancelled due to disease outbreak, 
and the Asian Medical Students’ Exchange 
Program would not be resumed until next 
January31. These adaptive measurements 
are mandatory in this unprecedented situa-
tion, whilst might also change the mode of 
medical education both for now and even 
for the upcoming future.  
As a matter of fact, alteration in the 
form of physician cultivation usually came 
after a major health crisis by which the 
suboptimal aspects of capacity building 
were illuminated. For instance, after 2003 
SARS-CoV outbreak in Taiwan, it was no-
table that the general medical training was 
rather insufficient. After the pandemic sub-
sided, Ministry of Health and Welfare at 
that time drafted the “post graduate year 
(PGY) doctor” proposal before residency 
for naïve licensed personnel32,33. The pur-
poses were to solidify the knowledge on the 
independent management of general dis-
eases and to compensate for the conse-
quences of premature specification in ca-
reer planning34. In 2019, the training length 
of PGY program was extended from a year 
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to two. Currently, the officials are consider-
ing further reformation of the present 
agenda, such as curriculum rearrangement 
to add in more training on public health and 
infection control. It is foreseeable that the 
medical education would remain dynamic 
and echo the clinical demand. 
 
Future perspective 
The evolution of COVID-19 pan-
demic is rapid, and it is still enigmatic when 
the crisis will regress. As Ms. President 
Ing-Wen Tsai of Taiwan addressed that “we 
are in the same boat35,” multi-disciplinary 
involvement became vital to tackle the sit-
uation. Medical schools and teaching hos-
pitals in the island cooperated to develop 
vaccination, novel medications, as well as 
intellectual platform to monitor the clinical 
conditions of individuals under quarantine, 
track exposure history, and automatically 
issue corresponding alert. Besides, short-
coming of the present healthcare system 
and medical training curriculum will be re-
viewed after this emergent condition to bet-
ter prepare for future disease outbreak. We 
also learned the conundrum that during crit-
ical time, admeasurement of scarce medical 
apparatus such as ventilator could be a 
heart-breaking challenge36. Strengthening 
the public health system is an urgent neces-
sity37. Incorporation of the artificial intelli-
gence and big data library for future infec-
tion control, epidemiological statistics, and 
to realize individualized therapeutic ar-
rangement, albeit still in its infancy, en-
lightened a new avenue to advance our 
medical capacity and capability. 
 
Conclusion 
The global impact of COVID-19 
tsunami is profound. Confirmed cases ex-
ceeded medical capacities in several coun-
tries, and death toll continued to accumu-
late. Thus far, the outbreak in Taiwan was 
fortunately amendable, and the measures 
authority put in action could be reproduci-
ble should future public health crisis be en-
countered (Figure 3). Allocation system of 
surgical mask distribution, transparency of 
present-day information, traffic control 
bundle inside the hospital, and pharmaceu-
tical logistics are the cornerstones to over-
come the pandemic. Transformation of 
medical training and the influence on med-
ical students were also approached. Lesson 
learned in this human tragedy is devastated, 
but it will eventually enhance our public 
health scheme and medical competence. 
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